Marvin S. Hausman MD to discuss screening program at ASCO MIAMI, FLORIDA / ACCESS Newswire / April 29, 2025 / Ludwig Enterprises, Inc. (the "Company") today announced the acceptance for publication in ...

SAN JUAN CAPISTRANO, CALIFORNIA / ACCESS Newswire / April 29, 2025 / Alter Behavioral Health announces the grand opening of its new Luxury Residential Crisis Center in San Juan Capistrano. This ...

Collaboration combines Scipher's unique RNAseq data, part of the largest non-oncology clinico-transcriptomic data lake and biobank, with InnoSIGN's proprietary Comprehensive Pathway Analysis (CPA) ...

New manufacturing deal positions CBDL to tap into the $4.9 billion Latin American CBD market, unlocking major revenue growth ...

Awaited Advancement in Non-Invasive Radiofrequency Skin Tightening Is Now Approved for the Canadian Market LAVAL, QC / ACCESS Newswire / April 29, 2025 / Bausch Health Companies Inc.

Miscellaneous29.04.2025 / 14:01 CET/CESTThe issuer is solely responsible for the content of this announcement. Mainz Biomed Enters into Technology Partnership with EDX Medical GroupBERKELEY, US and ...

Cantargia (Cantargia AB (publ); Nasdaq Stockholm:CANTA) will publish the company's interim report for the first quarter of 2025 on Tuesday, May 13, 2025, at 07:00 a.m. CEST.In conjunction to the ...

LUND, SE / ACCESS Newswire / April 29, 2025 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and first-in-class ...

SHELTON, CT / ACCESS Newswire / April 29, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a leading global pioneer in the development of broad-spectrum ...

In 2023, the myotonic dystrophy treatment market is projected to be worth USD 874.39 million. The global demand for myotonic dystrophy treatment is anticipated to increase at a CAGR of 12.3% between ...

The global isovaleric acidemia treatment market is poised for remarkable growth, projected to rise from USD 652.28 million in 2023 to USD 1,125.15 million by 2033, reflecting a robust CAGR of 5.6%.

According to Future Market Insights, myelofibrosis (mf) treatment market is expected to grow at a CAGR of 5.5% between 2023 and 2033, reaching USD 1,280 Million by 2033. The market is expected to ...